These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 6391406)

  • 1. The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection.
    Levey AS
    Arch Intern Med; 1984 Dec; 144(12):2382-7. PubMed ID: 6391406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved results of renal transplantation in diabetic nephropathy.
    Wilczek H; Gunnarsson R; Lundgren G; Ost L
    Transplant Proc; 1984 Jun; 16(3):623-7. PubMed ID: 6375029
    [No Abstract]   [Full Text] [Related]  

  • 3. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.
    Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D
    Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion.
    Takahashi K; Yagisawa T; Tanabe I; Teraoka S; Hayasaka Y; Yasuo M; Fuchinoue S; Honda H; Toma H; Agishi T
    Transplant Proc; 1987 Oct; 19(5):3655-60. PubMed ID: 2960043
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical renal transplantation.
    Sommer BG; Ferguson RM; Najarian JS
    Urol Clin North Am; 1983 Feb; 10(1):149-59. PubMed ID: 6340311
    [No Abstract]   [Full Text] [Related]  

  • 6. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation.
    Rao KV; Andersen RC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1652. PubMed ID: 2652540
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal transplantation (second of two parts).
    Guttmann RD
    N Engl J Med; 1979 Nov; 301(19):1038-48. PubMed ID: 386122
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving results in primary diabetic renal transplantation.
    Zincke H; Engen DE; Sterioff S; McDonald MW; Frohnert PP; Johnson WJ
    Transplant Proc; 1984 Jun; 16(3):617-20. PubMed ID: 6375028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
    Sutherland DE; Fryd DS; Strand M; Ascher N; Simmons RL; Najarian JS
    Transplant Proc; 1984 Jun; 16(3):629-32. PubMed ID: 6375030
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current immunologic aspects of kidney transplantation].
    Lenhard V; Dreikorn K; Opelz G
    Urologe A; 1982 Sep; 21(5):280-9. PubMed ID: 6758280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC
    Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract]   [Full Text] [Related]  

  • 15. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal transplantation at the University of Wisconsin in the cyclosporine era.
    Knechtle SJ; Pirsch JD; D'Alessandro AM; Sollinger HW; Kalayoglu M; Belzer FO
    Clin Transpl; 1993; ():211-8. PubMed ID: 7918154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uselessness of donor-specific transfusions or prophylactic ALG with therapeutic cyclosporine doses in living related renal transplantation between one-haplotype matched pairs.
    Yamauchi J; Akiyama N; Sugimoto H; Tomikawa S; Mita K; Bekku Y; Ogawa Y; Imai T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1663-6. PubMed ID: 2652545
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of DR and DR6 matching on cadaver kidney transplant survival.
    Reyman TA; Toledo-Pereyra LH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
    [No Abstract]   [Full Text] [Related]  

  • 19. Minnesota experience with 81 pancreas transplants since 1978.
    Sutherland DE; Chinn PL; Goetz FC; Elick BA; Najarian JS
    Transplant Proc; 1984 Jun; 16(3):695-703. PubMed ID: 6375036
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
    Hourmant M; Soulillou JP
    Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.